v3.26.1
Stockholders’ Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Shares and Warrants Reserved for Issuance Shares of common stock reserved for issuance, on an as-converted basis, are as follows:
December 31, 2025March 31, 2026
Options issued and outstanding9,204,983 9,220,829 
Restricted stock units outstanding2,276,156 4,743,205 
Performance-based restricted stock units outstanding
— 1,726,737 
Shares available for future issuance under 2020 plan10,922,232 7,469,133 
Shares available for issuance under employee stock purchase plan4,140,207 4,943,276 
Total26,543,578 28,103,180 
Schedule of Stock Option Activity
The following table summarizes stock option activity for the three months ended March 31, 2026:
Number of OptionsWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contractual Life (years)Aggregate
Intrinsic
Value
Balances at December 31, 20259,204,983 $23.11 5.3$247,040 
Options granted134,675 27.23 
Options exercised(88,685)7.08 
Options cancelled and forfeited(30,144)25.44 
Balances at March 31, 20269,220,829 23.32 5.2103,883 
Options exercisable – March 31, 20267,399,833 20.18 4.498,214 
Options vested and expected to vest – March 31, 20269,207,104 $23.30 5.2$103,880 
Schedule of Restricted Stock Units and Restricted Stock The following table summarizes RSU activity for the three months ended March 31, 2026:
Number of SharesWeighted-Average Grant Date Fair Value Per Share
Unvested at December 31, 20252,276,156$47.43 
RSUs granted3,202,17227.45 
RSUs vested(602,976)52.16 
RSUs cancelled and forfeited(132,147)34.10 
Unvested at March 31, 20264,743,205$33.63 
Schedule of Performance-Based Restricted Stock Units
The following table summarizes PRSU activity for the three months ended March 31, 2026:
Number of SharesWeighted-Average Grant Date Fair Value Per Share
Unvested at December 31, 2025—$— 
PRSUs granted1,726,73756.20 
Unvested at March 31, 20261,726,737$56.20 
Schedule of Stock Options Fair Value Assumptions
The following assumptions were used to estimate the fair value of options granted:

Three Months Ended March 31,
20252026
Expected term (in years)
5.2 – 7.0
5.2 – 5.7
Expected volatility
50.66% – 53.33%
65.70%
Risk-free interest rate
3.96% – 4.09%
3.51% – 3.62%
Dividend yield—%—%
Schedule of Employee Stock Purchase Plan Fair Value Assumptions
The following assumptions were used to estimate the fair value of ESPP purchase rights:
Three Months Ended March 31,
20252026
Expected term (in years)0.50.5
Expected volatility99.09%71.86%
Risk-free interest rate4.34%3.59%
Dividend yield—%—%
Schedule of Share-Based Payment Award, Performance Restricted Stock Units, Valuation Assumptions
The following assumptions were used to estimate the fair value of PRSUs granted:

Three Months Ended March 31,
2026
Expected term (in years)
3.9 – 4.0
Expected volatility
93.23% – 94.73%
Risk-free interest rate
3.42% – 3.82%
Dividend yield—%
Schedule of Stock-based Compensation Expense
The Company recorded stock-based compensation in the following expense categories in its condensed consolidated statements of operations and comprehensive loss for employees and non-employees:
Three Months Ended March 31,
20252026
Sales and marketing$2,703 $3,026 
Customer operations1,646 1,895 
Engineering and product development14,552 18,754 
General, administrative, and other10,930 11,136 
Total$29,831 $34,811